Preprint · CC-BY
via OpenAlex
Ketamine treatment effects on DNA methylation and Epigenetic Biomarkers of aging
Kristin Dawson, Athena May Jean M. Carangan, Jessica Klunder, Natàlia Carreras-Gallo, Raghav Sehgal, Samantha Megilligan, Benjamin C. Askins, Nicole Perkins, Tavis L. Mendez, Ryan C. Smith, M. Dawson, Michael P. Mallin, Albert Higgins‐Chen, Varun Bhamidipati Dwaraka
medRxiv · 2024 · ▲ 4 citations
Abstract
Abstract Major depressive disorder (MDD) and posttraumatic stress disorder (PTSD) are debilitating psychiatric conditions associated with poor health outcomes similarly observed in non-pathological aging. Ketamine is a dissociative anesthetic and NMDA receptor antagonist with demonstrated rapid reduction in symptoms associated with Treatment Resistant Depression (TRD) and PTSD. Ketamine’s effects on biological aging have not been extensively studied among patients with moderate to severe symptoms of depression and/or trauma. To address this gap, this study looked at the changes in non-epigenetic measures, DNA methylation levels, immune cell composition, and biological age based on various epigenetic biomarkers of aging, of 20 participants at baseline and after completion of a 2-3 week treatment course of 0.5 mg/kg ketamine infusions in individuals with MDD or PTSD. As expected, depression and PTSD scores decreased in participants following ketamine infusion treatments as measured by the PHQ-9 and PCL-5. We observed a reduction in epigenetic age in the OMICmAge, GrimAge V2, and PhenoAge biomarkers. In order to better understand the changes in epigenetic age, we also looked at the underlying levels of various Epigenetic Biomarker Proxies (EBPs) and surrogate protein markers and found significant changes following ketamine treatment. The results are consistent with existing literature on ketamine’s effects on different biomarkers. These results underline the ability of GrimAge V2, PhenoAge, and OMICmAge in particular, to capture signals associated with key clinical biomarkers, and add to the growing body of literature on ketamine’s epigenetic mechanisms and their effect on biological aging.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1101/2024.09.10.24313258
- Canonical
- link ↗
- Fetched
- 2026-11-02 MST
Cite this
APA
Dawson, K., Carangan, A.M.J.M., Klunder, J., Carreras-Gallo, N., Sehgal, R., Megilligan, S., Askins, B.C., Perkins, N., Mendez, T.L., Smith, R.C., Dawson, M., Mallin, M.P., Higgins‐Chen, A., & Dwaraka, V.B. (2024). Ketamine treatment effects on DNA methylation and Epigenetic Biomarkers of aging. <em>medRxiv</em>. https://doi.org/10.1101/2024.09.10.24313258
Vancouver
Dawson K, Carangan AMJM, Klunder J, Carreras-Gallo N, Sehgal R, Megilligan S, et al. Ketamine treatment effects on DNA methylation and Epigenetic Biomarkers of aging. medRxiv. 2024. doi:10.1101/2024.09.10.24313258.
BibTeX
@unpublished{kristin2024Ketami,
title = {Ketamine treatment effects on DNA methylation and Epigenetic Biomarkers of aging},
author = {Kristin Dawson and Athena May Jean M. Carangan and Jessica Klunder and Natàlia Carreras-Gallo and Raghav Sehgal and Samantha Megilligan and Benjamin C. Askins and Nicole Perkins and Tavis L. Mendez and Ryan C. Smith and M. Dawson and Michael P. Mallin and Albert Higgins‐Chen and Varun Bhamidipati Dwaraka},
journal = {medRxiv},
year = {2024},
doi = {10.1101/2024.09.10.24313258},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Translational Psychiatry 2025
Open access · CC-BY
Epigenetic aging and DNA methylation biomarker changes following ketamine treatment in patients with MDD and PTSD: a pilot study
TruDiagnostic 2022
Open access · US-GOV
Impact of Ketamine on Epigenetic Age (IKEA)
Clinical Epigenetics 2019
Open access · CC-BY
Particulate matter exposure shapes DNA methylation through the lifespan
Springer eBooks 2024
Citation only
Biological Age and Aging Clock: DNA Methylation and Biological Age
The Journals of Gerontology Series B 2025
Preprint · OA
How does life course exposure to contextual disadvantage accelerate biological aging? The role of psychological symptoms
The journals of gerontology. Series B, Psychological sciences and social sciences 2025
Citation only